News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
739,201 Results
Type
Article (66601)
Company Profile (349)
Press Release (672229)
Multimedia
Podcasts (167)
Webinars (32)
Section
Business (202076)
Career Advice (2406)
Deals (33444)
Drug Delivery (126)
Drug Development (83400)
Employer Resources (149)
FDA (16283)
Job Trends (14652)
News (341392)
Policy (30827)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2905)
Academic (2)
Accelerated approval (39)
Adcomms (24)
Allergies (166)
Alliances (52363)
ALS (205)
Alzheimer's disease (1842)
Antibody-drug conjugate (ADC) (395)
Approvals (16575)
Artificial intelligence (659)
Autoimmune disease (240)
Automation (50)
Bankruptcy (304)
Best Places to Work (11399)
BIOSECURE Act (18)
Biosimilars (194)
Biotechnology (241)
Bladder cancer (172)
Brain cancer (69)
Breast cancer (700)
Cancer (5464)
Cardiovascular disease (465)
Career advice (2044)
Career pathing (42)
CAR-T (317)
CDC (49)
Celiac Disease (1)
Cell therapy (869)
Cervical cancer (41)
Clinical research (71136)
Collaboration (2056)
Company closure (6)
Compensation (1169)
Complete response letters (76)
COVID-19 (2859)
CRISPR (106)
C-suite (1011)
Cystic fibrosis (153)
Data (7172)
Decentralized trials (3)
Denatured (63)
Depression (170)
Dermatology (57)
Diabetes (549)
Diagnostics (6813)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (43)
Drug discovery (334)
Drug pricing (179)
Drug shortages (24)
Duchenne muscular dystrophy (259)
Earnings (84692)
Editorial (64)
Employer branding (19)
Employer resources (136)
Events (116667)
Executive appointments (1072)
FDA (19731)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1680)
Gene editing (228)
Generative AI (67)
Gene therapy (697)
GLP-1 (1062)
Government (4373)
Grass and pollen (7)
Guidances (396)
Healthcare (18485)
HIV (71)
Huntington's disease (54)
IgA nephropathy (94)
Immunology and inflammation (292)
Immuno-oncology (86)
Indications (156)
Infectious disease (3177)
Inflammatory bowel disease (216)
Inflation Reduction Act (17)
Influenza (132)
Intellectual property (278)
Interviews (436)
IPO (16059)
IRA (51)
Job creations (3618)
Job search strategy (1708)
JPM (64)
Kidney cancer (18)
Labor market (83)
Layoffs (570)
Leadership (38)
Legal (6898)
Liver cancer (99)
Longevity (27)
Lung cancer (723)
Lymphoma (409)
Machine learning (53)
Management (50)
Manufacturing (938)
MASH (188)
Medical device (13590)
Medtech (13666)
Mergers & acquisitions (18559)
Metabolic disorders (1425)
mRNA (202)
Multiple sclerosis (174)
NASH (20)
Neurodegenerative disease (413)
Neuropsychiatric disorders (109)
Neuroscience (3309)
Neurotech (1)
NextGen: Class of 2026 (6410)
Non-profit (4635)
Now hiring (60)
Obesity (653)
Opinion (323)
Ovarian cancer (188)
Pain (236)
Pancreatic cancer (267)
Parkinson's disease (357)
Partnered (37)
Patents (566)
Patient recruitment (609)
Peanut (62)
People (60146)
Pharmaceutical (76)
Pharmacy benefit managers (24)
Phase 1 (22335)
Phase 2 (31282)
Phase 3 (23164)
Pipeline (7187)
Policy (287)
Postmarket research (2797)
Preclinical (10045)
Press Release (72)
Prostate cancer (287)
Psychedelics (56)
Radiopharmaceuticals (325)
Rare diseases (1046)
Real estate (6047)
Recruiting (63)
Regulatory (24489)
Reports (44)
Research institute (2710)
Resumes & cover letters (365)
Rett syndrome (33)
RNA editing (19)
RSV (85)
Schizophrenia (175)
Series A (284)
Series B (207)
Service/supplier (15)
Sickle cell disease (107)
Special edition (26)
Spinal muscular atrophy (172)
Sponsored (50)
Startups (3838)
State (1)
Stomach cancer (18)
Supply chain (110)
Tariffs (66)
The Weekly (101)
Vaccines (1126)
Venture capital (98)
Weight loss (423)
Women's health (104)
Worklife (21)
Date
Today (173)
Last 7 days (726)
Last 30 days (2812)
Last 365 days (30738)
2026 (8120)
2025 (30982)
2024 (35775)
2023 (40548)
2022 (51810)
2021 (56126)
2020 (53972)
2019 (46234)
2018 (35052)
2017 (33521)
2016 (33281)
2015 (39388)
2014 (32642)
2013 (28705)
2012 (29370)
2011 (29597)
2010 (27924)
Location
Africa (943)
Alabama (99)
Alaska (6)
Arizona (290)
Arkansas (14)
Asia (44493)
Australia (7765)
California (12236)
Canada (3472)
China (1296)
Colorado (516)
Connecticut (541)
Delaware (369)
Europe (102257)
Florida (1851)
Georgia (387)
Hawaii (3)
Idaho (50)
Illinois (910)
India (83)
Indiana (540)
Iowa (21)
Japan (504)
Kansas (135)
Kentucky (43)
Louisiana (39)
Maine (78)
Maryland (1502)
Massachusetts (8868)
Michigan (365)
Minnesota (689)
Mississippi (5)
Missouri (141)
Montana (36)
Nebraska (29)
Nevada (135)
New Hampshire (81)
New Jersey (3303)
New Mexico (33)
New York (3257)
North Carolina (1629)
North Dakota (9)
Northern California (6015)
Ohio (371)
Oklahoma (23)
Oregon (41)
Pennsylvania (2419)
Puerto Rico (21)
Rhode Island (46)
South America (1218)
South Carolina (78)
Southern California (4816)
Tennessee (190)
Texas (1934)
United States (43587)
Utah (369)
Vermont (1)
Virginia (311)
Washington D.C. (79)
Washington State (1010)
West Virginia (3)
Wisconsin (136)
Wyoming (2)
739,201 Results for "janssen research and development".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Johnson & Johnson celebrates innovation in cancer research with 2025 Dr. Paul Janssen Award
January 8, 2026
·
4 min read
Press Releases
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development
March 30, 2026
·
5 min read
Press Releases
Foundation Medicine Launches Whole Genome Sequencing Germline Test for Research Use to Accelerate Biopharmaceutical Research and Therapy Development Beyond Oncology
March 13, 2026
·
3 min read
Press Releases
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
April 3, 2026
·
11 min read
Press Releases
Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
April 3, 2026
·
11 min read
Press Releases
Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development
March 23, 2026
·
4 min read
Press Releases
Palleon Pharmaceuticals to Present on Development of HLX316/E-688 at the American Association for Cancer Research (AACR) Annual Meeting
April 2, 2026
·
2 min read
Sponsored
Disruptive Innovation in Cancer Research: The New Era of Oncology
As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel methodologies, strategic innovation, and patient-centered approaches, MEDSIR is driving a new era in cancer research, one that accelerates development, enhances efficiency, and delivers more meaningful therapeutic progress for patients worldwide.
December 15, 2025
·
9 min read
Vaccines
FDA’s Makary Backs mRNA Vaccines but Says Companies ‘Can Fund Their Own Research’
In August last year, the Health Department cut around $500 million in mRNA research funding, with Health Secretary Robert F. Kennedy Jr. saying the agency would instead divert the money “toward safer, broader vaccine platforms.”
February 24, 2026
·
2 min read
·
Tristan Manalac
Press Releases
EpiFrontier Therapeutics Secures up to $32M Grant from the Japan Agency for Medical Research and Development to Advance Novel Therapy for Beta Globin Disorders
March 24, 2026
·
6 min read
1 of 73,921
Next
